📌 Key Takeaways
- Topic: Nano Silica Supplier: How to Verify Particle Size, Purity and Consistency
- Keywords: alumina powder
- Published: 2026-11-20 05:05:41
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Kaolin vs Silica: Filler Properties, Uses and Selection Guide
- Silica Market Trends 2026: Demand Drivers, Technologies and Regional Outlook
- Zeng, G. & Chen, Y. Surface modification of black phosphorus-based nanomaterials in biomedical applications: Strategies and recent advances. Acta Biomater. 118, 1-17 (2020). Post CAS PubMed Google Scholar
- Silica MSDS: How to Read It and What Safety Information to Check
- Cai, D. et al. Chitosan-capped enzyme-responsive hollow mesoporous silica nanoplatforms for colon-specific drug delivery. Nanoscale Res. Lett. 15, 123 (2020). Article CAS PubMed Central PubMed Google Scholar
- What Is the Melting Point of Silica? Values for Quartz, Cristobalite and Fused Silica
- Silica Nanoparticles: Synthesis, Properties, Safety and Applications
Silica Supplier Middle East: Sourcing Options, Logistics and Key Markets
What is silica (SiO₂)?
wood coating matting agent Dostert, C. et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674-677 (2008). Piece CAS PubMed Central PubMed Google Scholar
What is the difference between fumed silica and precipitated silica?
quartz powder
What drives silica raw material prices?
E551 The unique properties of MSNs make it greatly superior for the construction of multifunctional nanocomposites and drug delivery system. Different therapeutic nanoplatforms obtained through the careful design of MSNs have revealed promising potential in the field of targeted disease therapy. Current applications of MSNs include tumor therapy, 367, 368, 369 anti-infection therapy (bacteria and virus), 370, 371, 372, 373 anti-oxidant/anti-inflammatory therapy (Alzheimer's disease, acute kidney injury, etc.), 374, 375, 376 and metabolic diseases treatment (diabetes, osteoporosis, fatty liver, etc) 377, 378, 379, 380 (Fig. 7 ). In general, the targeted therapeutic characteristics of MSNs can be reflected in the following aspects: (1) Loading chemotherapy drugs or other drugs with toxic side influences, so that they can be released in a controlled manner by MSNs at the targeted sites to prevent their premature release. (2) Selective enrichment at the lesion sites through passive targeting or active targeting, resulting in the higher therapeutic efficacy. (3) Use the MSNs matrix to develop a non-invasive, spatial and temporal controllable targeted therapeutic plan, consequently to overcome the limitations and defects of conventional clinical treatment modalities. To date, the emerging targeted therapeutic modalities developed based on MSNs include dynamic therapy such as photodynamic, sonodynamic and chemodynamic therapies, thermal ablation therapy such as photothermal therapy and magnetic thermotherapy, enzyme-like catalytic therapy, immunotherapy, gene therapy, and others. Meanwhile, the integration of various therapeutic modalities on a single MSNs is expected to enhance the therapeutic efficacy synergistically (Fig. 7 ). In this part, we will discuss MSNs-based therapeutic modalities.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.